KR102362422B1 - 약물 사용에 대한 개인화된 추천정보를 제공하기 위한 웹 기반의 컴퓨터 이용 방법, 시스템 및 컴퓨터 판독가능 매체 - Google Patents

약물 사용에 대한 개인화된 추천정보를 제공하기 위한 웹 기반의 컴퓨터 이용 방법, 시스템 및 컴퓨터 판독가능 매체 Download PDF

Info

Publication number
KR102362422B1
KR102362422B1 KR1020167018777A KR20167018777A KR102362422B1 KR 102362422 B1 KR102362422 B1 KR 102362422B1 KR 1020167018777 A KR1020167018777 A KR 1020167018777A KR 20167018777 A KR20167018777 A KR 20167018777A KR 102362422 B1 KR102362422 B1 KR 102362422B1
Authority
KR
South Korea
Prior art keywords
information
drug
personalized
genetic
patient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020167018777A
Other languages
English (en)
Korean (ko)
Other versions
KR20160099618A (ko
Inventor
죠르디 프랏세발 가르시아
다비드 레돈도 아마도
미겔 뚜손 세가라
실비아 빌체스 사에스
죠르디 에스파데르 마소
아리아나 살라베르트 라로사
미겔 앙헬 보나체라 시에라
Original Assignee
에이비-바이오틱스 에세.아.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 에이비-바이오틱스 에세.아. filed Critical 에이비-바이오틱스 에세.아.
Publication of KR20160099618A publication Critical patent/KR20160099618A/ko
Application granted granted Critical
Publication of KR102362422B1 publication Critical patent/KR102362422B1/ko
Assigned to 프리시젼 몰레큘러 솔루션즈 엘엘시 reassignment 프리시젼 몰레큘러 솔루션즈 엘엘시 권리의 전부이전등록 Assignors: 에이비-바이오틱스 에세.아.
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16C—COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
    • G16C20/00—Chemoinformatics, i.e. ICT specially adapted for the handling of physicochemical or structural data of chemical particles, elements, compounds or mixtures
    • G16C20/30—Prediction of properties of chemical compounds, compositions or mixtures
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4836—Diagnosis combined with treatment in closed-loop systems or methods
    • A61B5/4839—Diagnosis combined with treatment in closed-loop systems or methods combined with drug delivery
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16C—COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
    • G16C20/00—Chemoinformatics, i.e. ICT specially adapted for the handling of physicochemical or structural data of chemical particles, elements, compounds or mixtures
    • G16C20/10—Analysis or design of chemical reactions, syntheses or processes
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16C—COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
    • G16C20/00—Chemoinformatics, i.e. ICT specially adapted for the handling of physicochemical or structural data of chemical particles, elements, compounds or mixtures
    • G16C20/90—Programming languages; Computing architectures; Database systems; Data warehousing
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/60—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H70/00—ICT specially adapted for the handling or processing of medical references
    • G16H70/40—ICT specially adapted for the handling or processing of medical references relating to drugs, e.g. their side effects or intended usage
    • H—ELECTRICITY
    • H04—ELECTRIC COMMUNICATION TECHNIQUE
    • H04L—TRANSMISSION OF DIGITAL INFORMATION, e.g. TELEGRAPHIC COMMUNICATION
    • H04L41/00—Arrangements for maintenance, administration or management of data switching networks, e.g. of packet switching networks
    • H04L41/22—Arrangements for maintenance, administration or management of data switching networks, e.g. of packet switching networks comprising specially adapted graphical user interfaces [GUI]
    • H—ELECTRICITY
    • H04—ELECTRIC COMMUNICATION TECHNIQUE
    • H04L—TRANSMISSION OF DIGITAL INFORMATION, e.g. TELEGRAPHIC COMMUNICATION
    • H04L67/00—Network arrangements or protocols for supporting network services or applications
    • H04L67/01—Protocols
    • H04L67/02—Protocols based on web technology, e.g. hypertext transfer protocol [HTTP]

Landscapes

  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medical Informatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Theoretical Computer Science (AREA)
  • Public Health (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Epidemiology (AREA)
  • Primary Health Care (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Computing Systems (AREA)
  • Analytical Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Evolutionary Biology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Signal Processing (AREA)
  • Computer Networks & Wireless Communication (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pathology (AREA)
  • Human Computer Interaction (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Software Systems (AREA)
  • Databases & Information Systems (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
KR1020167018777A 2013-12-12 2014-12-10 약물 사용에 대한 개인화된 추천정보를 제공하기 위한 웹 기반의 컴퓨터 이용 방법, 시스템 및 컴퓨터 판독가능 매체 Expired - Fee Related KR102362422B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361915077P 2013-12-12 2013-12-12
US61/915,077 2013-12-12
PCT/IB2014/002715 WO2015087140A1 (en) 2013-12-12 2014-12-10 Web-based computer-aided method and system for providing personalized recommendations about drug use, and a computer-readable medium

Publications (2)

Publication Number Publication Date
KR20160099618A KR20160099618A (ko) 2016-08-22
KR102362422B1 true KR102362422B1 (ko) 2022-02-11

Family

ID=52434853

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020167018777A Expired - Fee Related KR102362422B1 (ko) 2013-12-12 2014-12-10 약물 사용에 대한 개인화된 추천정보를 제공하기 위한 웹 기반의 컴퓨터 이용 방법, 시스템 및 컴퓨터 판독가능 매체

Country Status (7)

Country Link
US (1) US10943672B2 (https=)
EP (1) EP3080738A1 (https=)
JP (1) JP6596424B2 (https=)
KR (1) KR102362422B1 (https=)
CN (1) CN105981024B (https=)
CA (1) CA2932983C (https=)
WO (1) WO2015087140A1 (https=)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3239869A1 (en) 2016-04-29 2017-11-01 Fujitsu Limited A system and method to produce and validate weighted relations between drug and adverse drug reactions
CN106326652A (zh) * 2016-08-23 2017-01-11 北京博奥医学检验所有限公司 一种肿瘤智能用药指导系统
US10621558B2 (en) 2016-10-07 2020-04-14 Bank Of America Corporation System for automatically establishing an operative communication channel to transmit instructions for canceling duplicate interactions with third party systems
US10510088B2 (en) * 2016-10-07 2019-12-17 Bank Of America Corporation Leveraging an artificial intelligence engine to generate customer-specific user experiences based on real-time analysis of customer responses to recommendations
US10476974B2 (en) 2016-10-07 2019-11-12 Bank Of America Corporation System for automatically establishing operative communication channel with third party computing systems for subscription regulation
WO2018140156A1 (en) * 2017-01-27 2018-08-02 Orig3N, Inc. Systems and methods for determining and presenting purchase recommendations based on personal genetic profiles
CN108629149B (zh) * 2017-03-21 2023-04-07 达易特基因科技股份有限公司 基因检测平台方法
CN120636518A (zh) * 2017-05-12 2025-09-12 密歇根大学董事会 个体和队列药理学表型预测平台
CN107273710A (zh) * 2017-08-22 2017-10-20 北京岙特杰诺生物科技有限公司 一种建立药物代谢酶基因与药物代谢的关系模型的方法
JP7320345B2 (ja) * 2017-10-27 2023-08-03 シスメックス株式会社 遺伝子解析方法、遺伝子解析装置、遺伝子解析システム、プログラム、および記録媒体
WO2019083024A1 (ja) * 2017-10-27 2019-05-02 シスメックス株式会社 遺伝子解析方法、遺伝子解析装置、管理サーバ、遺伝子解析システム、プログラム、および記録媒体
CA3080468A1 (en) 2017-10-30 2019-05-09 Endocanna Health, Inc. Cannabinoid formulations
CN108682458A (zh) * 2018-05-08 2018-10-19 北京岙特杰诺生物科技有限公司 用药管理方法、装置及电子设备
WO2020005321A1 (en) * 2018-06-28 2020-01-02 Powell Roberta D Patient-facing digital platform for health literacy and numeracy
US20200004928A1 (en) * 2018-06-29 2020-01-02 Roche Sequencing Solutions, Inc. Computing device with improved user interface for interpreting and visualizing data
IT201800007351A1 (it) * 2018-07-19 2020-01-19 Sistema e metodo attuato mediante calcolatore per visualizzazione dinamica d’interazione tra farmaci
WO2020091375A2 (ko) * 2018-10-29 2020-05-07 고려대학교 산학협력단 항우울제 추천 방법 및 시스템
US20220310208A1 (en) * 2019-06-13 2022-09-29 Roche Sequencing Solutions, Inc. Systems and methods with improved user interface for interpreting and visualizing longitudinal
EP3822974A1 (en) * 2019-11-15 2021-05-19 Stalicla S.A. Computational platform to identify therapeutic treatments for neurodevelopmental conditions
KR20210096402A (ko) * 2020-01-28 2021-08-05 (주)인테그로메디랩 증례 데이터 기반 천연물 추천 장치 및 방법
KR20210103338A (ko) 2020-02-13 2021-08-23 윤명철 유전자 정보를 이용하는 상품 추천 시스템 및 방법
US11238967B1 (en) * 2021-02-24 2022-02-01 Flatiron Health, Inc. Systems and methods for generating dynamic graphical user interfaces for dose recalculations and adjustments
KR102918109B1 (ko) * 2021-06-07 2026-01-28 (주) 애니펜 콘텐츠를 제공하기 위한 방법, 시스템 및 비일시성의 컴퓨터 판독 가능 기록 매체
WO2024053860A1 (ko) 2022-09-05 2024-03-14 주식회사 지놈인사이트테크놀로지 유전 정보 분석 결과 제공 방법 및 시스템
KR102834065B1 (ko) * 2022-09-22 2025-07-16 서울대학교산학협력단 약동학적 변화량 예측 장치 및 방법
CN120641989A (zh) * 2022-10-06 2025-09-12 蓝色基因实验室有限责任公司 药物相互作用分析的系统和方法
KR102659367B1 (ko) * 2023-08-04 2024-04-22 웰트 주식회사 멀티소스 데이터 분석을 기반으로 한 맞춤형 디지털 치료제 생성 방법 및 이러한 방법을 수행하는 장치
CN118737369B (zh) * 2024-06-07 2025-07-01 武汉海云健康科技股份有限公司 一种基于多任务学习的个性化用药推荐方法、设备及存储介质
CN118737311B (zh) * 2024-09-03 2024-11-22 艾伟拓(江苏)医药科技有限公司 一种二甲氨丁酸二亚油甲酯配伍方法

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060034508A1 (en) 2004-06-07 2006-02-16 Zhou Xiang S Computer system and method for medical assistance with imaging and genetics information fusion
US20060084071A1 (en) 2004-10-20 2006-04-20 University Of Washington Drug targets for the treatment of neurodegenerative disorders
JP2012502398A (ja) 2008-09-12 2012-01-26 ナビジェニクス インコーポレイティド 複数の環境的リスク因子及び遺伝的リスク因子を組み込む方法及びシステム
US20140304270A1 (en) 2011-10-31 2014-10-09 The Scripps Research Institute Systems and Methods for Genomic Annotation and Distributed Variant Interpretation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3703058A1 (en) * 2005-11-29 2020-09-02 Children's Hospital Medical Center A method of selecting a medication for a patient
US8099298B2 (en) * 2007-02-14 2012-01-17 Genelex, Inc Genetic data analysis and database tools
CN102067142A (zh) * 2008-02-26 2011-05-18 普渡研究基金会 用于患者基因分型的方法
CN101429544A (zh) * 2008-12-18 2009-05-13 黄行许 利用rna干扰文库筛选肿瘤化疗药物敏感基因的方法
US20110082867A1 (en) * 2009-10-06 2011-04-07 NeX Step, Inc. System, method, and computer program product for analyzing drug interactions

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060034508A1 (en) 2004-06-07 2006-02-16 Zhou Xiang S Computer system and method for medical assistance with imaging and genetics information fusion
US20060084071A1 (en) 2004-10-20 2006-04-20 University Of Washington Drug targets for the treatment of neurodegenerative disorders
JP2012502398A (ja) 2008-09-12 2012-01-26 ナビジェニクス インコーポレイティド 複数の環境的リスク因子及び遺伝的リスク因子を組み込む方法及びシステム
US20140304270A1 (en) 2011-10-31 2014-10-09 The Scripps Research Institute Systems and Methods for Genomic Annotation and Distributed Variant Interpretation

Also Published As

Publication number Publication date
CA2932983A1 (en) 2015-06-18
CA2932983C (en) 2021-06-08
JP6596424B2 (ja) 2019-10-23
CN105981024B (zh) 2019-03-26
US10943672B2 (en) 2021-03-09
US20160314251A1 (en) 2016-10-27
EP3080738A1 (en) 2016-10-19
WO2015087140A1 (en) 2015-06-18
KR20160099618A (ko) 2016-08-22
CN105981024A (zh) 2016-09-28
JP2017503258A (ja) 2017-01-26

Similar Documents

Publication Publication Date Title
KR102362422B1 (ko) 약물 사용에 대한 개인화된 추천정보를 제공하기 위한 웹 기반의 컴퓨터 이용 방법, 시스템 및 컴퓨터 판독가능 매체
van der Velde et al. MOLGENIS research: advanced bioinformatics data software for non-bioinformaticians
Wang et al. Identifying major impact factors affecting the continuance intention of mHealth: a systematic review and multi-subgroup meta-analysis
JP2017503258A5 (https=)
Trochim et al. Concept mapping: an introduction to structured conceptualization in health care
Dilla et al. Systematic review of the economic aspects of nonadherence to antipsychotic medication in patients with schizophrenia
Whalley Buono et al. Coming full circle in the measurement of medication adherence: opportunities and implications for health care
Popejoy et al. Quantifying care coordination using natural language processing and domain-specific ontology
Duke et al. Adherence to drug—drug interaction alerts in high-risk patients: a trial of context-enhanced alerting
Danahey et al. Simplifying the use of pharmacogenomics in clinical practice: building the genomic prescribing system
Eugene et al. A pharmacodynamic modelling and simulation study identifying gender differences of daily olanzapine dose and dopamine D2-receptor occupancy
Bartsch et al. A web-portal for interactive data exploration, visualization, and hypothesis testing
US20170329915A1 (en) Systems and methods for generating a modular web page template to display personal genetic and physiological condition information
Saadatagah et al. Clonal hematopoiesis risk score and all-cause and cardiovascular mortality in older adults
Cadamuro et al. Presentation and formatting of laboratory results: a narrative review on behalf of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Working Group “postanalytical phase”(WG-POST)
US20120130743A1 (en) Computer-Implemented Method for Medical Diagnosis Support
US20140229191A1 (en) Prescription decision support system and method using comprehensive multiplex drug monitoring
Senapati et al. Enriching healthcare service quality by leveraging service experiences in Indian private hospitals: application of fuzzy-AHP approach
Shyr et al. Usability study of clinical exome analysis software: top lessons learned and recommendations
Ma et al. Big data in pharmacy practice: current use, challenges, and the future
Kamath et al. Burden of death and disability due to adverse effects of medical treatment in India: An analysis using the global burden of disease 2019 study data
Rivier et al. Genal: a Python toolkit for genetic risk scoring and Mendelian randomization
Rothenbacher et al. New opportunities of real-world data from clinical routine settings in life-cycle management of drugs: example of an integrative approach in multiple sclerosis
Bachyrycz et al. Development and dissemination of a statewide system to minimize use of potentially inappropriate medications (PIMs)
Sarantis et al. Assessment of hospitals' websites in Portugal

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

P22-X000 Classification modified

St.27 status event code: A-2-2-P10-P22-nap-X000

P22-X000 Classification modified

St.27 status event code: A-2-2-P10-P22-nap-X000

P22-X000 Classification modified

St.27 status event code: A-2-2-P10-P22-nap-X000

A201 Request for examination
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R11-asn-PN2301

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R14-asn-PN2301

PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20250210

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

H13 Ip right lapsed

Free format text: ST27 STATUS EVENT CODE: N-4-6-H10-H13-OTH-PC1903 (AS PROVIDED BY THE NATIONAL OFFICE); TERMINATION CATEGORY : DEFAULT_OF_REGISTRATION_FEE

Effective date: 20250210

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20250210